Preprint · OA
via OpenAlex
Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies
Francisco J. Díaz, Sofía García, D Hernandez, Arie Regev, Adriana Rebelo, Jose Oca‐Cossio, Carlos T. Moraes
Gut · 2007 · ▲ 51 citations
Abstract
BACKGROUND: Although oxidative phosphorylation defects can affect the liver, these conditions are poorly understood, partially because of the lack of animal models. AIMS: To create and characterise the pathophysiology of mitochondrial hepatopathies in a mouse model. METHODS: A mouse model of mitochondrial hepatopathies was created by the conditional liver knockout (KO) of the COX10 gene, which is required for cytochrome c oxidase (COX) function. The onset and progression of biochemical, molecular and clinical phenotypes were analysed in several groups of animals, mostly at postnatal days 23, 56, 78 and 155. RESULTS: Biochemical and histochemical analysis of liver samples from 23-56-day-old KO mice showed liver dysfunction, a severe COX deficiency, marked mitochondrial proliferation and lipid accumulation. Despite these defects, the COX-deficient hepatocytes were not immediately eliminated, and apoptosis followed by liver regeneration could be observed only at age 78 days. Hepatocytes from 56-78-day-old KO mice survived despite very low COX activity but showed a progressive depletion of glycogen stores. In most animals, hepatocytes that escaped COX10 ablation were able to proliferate and completely regenerate the liver between days 78 and 155. CONCLUSIONS: The results showed that when faced with a severe oxidative phosphorylation defect, hepatocytes in vivo can rely on glycolysis/glycogenolysis for their bioenergetic needs for relatively long periods. Ultimately, defective hepatocytes undergo apoptosis and are replaced by COX-positive cells first observed in the perivascular regions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1136/gut.2006.119180
- Canonical
- link ↗
- Fetched
- 2026-06-01 MST
Cite this
APA
Díaz, F.J., García, S., Hernandez, D., Regev, A., Rebelo, A., Oca‐Cossio, J., & Moraes, C.T. (2007). Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. <em>Gut</em>. https://doi.org/10.1136/gut.2006.119180
Vancouver
Díaz FJ, García S, Hernandez D, Regev A, Rebelo A, Oca‐Cossio J, et al. Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Gut. 2007. doi:10.1136/gut.2006.119180.
BibTeX
@unpublished{francisco2007Pathop,
title = {Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies},
author = {Francisco J. Díaz and Sofía García and D Hernandez and Arie Regev and Adriana Rebelo and Jose Oca‐Cossio and Carlos T. Moraes},
journal = {Gut},
year = {2007},
doi = {10.1136/gut.2006.119180},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Hepatology 2023
Open access · CC-BY
Hepatic mitochondrial NAD+ transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis
Journal of Neurotrauma 2010
Preprint · OA
Age-Related Mitochondrial Changes after Traumatic Brain Injury
Molecular Neurodegeneration 2014
Open access · OA
Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer’s disease
Genes & Development 2007
Open access · OA
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Hepatology 2014
Preprint · OA
ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis
biorxiv 2024
Preprint · CC-BY